Edition:
India

Aptinyx Inc (APTX.OQ)

APTX.OQ on NASDAQ Stock Exchange Global Select Market

3.14USD
12:59am IST
Change (% chg)

$-0.08 (-2.48%)
Prev Close
$3.22
Open
$3.28
Day's High
$3.31
Day's Low
$3.12
Volume
21,748
Avg. Vol
67,608
52-wk High
$32.25
52-wk Low
$2.88

About

Aptinyx Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops therapies for disorders of the brain and nervous system. The Company has a platform for discovering compounds that work through a mechanism, which includes modulation of the N-methyl-D-aspartate (NMDA) receptor to develop pathways... (more)

Overall

No Ratios Available.

Financials

  APTX.OQ Industry Sector
P/E (TTM): -- 29.89 32.67
EPS (TTM): -- -- --
ROI: -- 14.89 14.48
ROE: -- 16.01 15.78

Allergan depression treatment fails studies, shares slip

Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell.

07 Mar 2019

UPDATE 2-Allergan depression treatment fails studies, shares slip

March 6 Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell.

07 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates